Your browser doesn't support javascript.
loading
Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.
Le Bourgeois, A; Labopin, M; Blaise, D; Ceballos, P; Vigouroux, S; Peffault de Latour, R; Marçais, A; Bulabois, C E; Bay, J O; Chantepie, S; Deconinck, E; Daguindau, E; Contentin, N; Yakoub-Agha, I; Cornillon, J; Mercier, M; Turlure, P; Charbonnier, A; Rorhlich, P S; N'Guyen, S; Maillard, N; Marchand, T; Mohty, M; Chevallier, P.
Afiliação
  • Le Bourgeois A; Department of Hematology, CHU Hôtel Dieu, Nantes.
  • Labopin M; Department of Hematology, Hôpital Saint Antoine, Paris.
  • Blaise D; Department of Hematology, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille.
  • Ceballos P; Department of Hematology, CHU St-Eloi, Clinique, Montpellier.
  • Vigouroux S; Department of Hematology, CHU de Bordeaux, Bordeaux.
  • Peffault de Latour R; Department of Hematology, Hôpital Saint Louis & Université Paris 7, Denis Diderot, Paris.
  • Marçais A; Department of Hematology, Hôpital Neker-Enfants Malades, Paris.
  • Bulabois CE; Department of Hematology, CHU de Grenoble, Grenoble.
  • Bay JO; Department of Hematology, CHU de Clermont Ferrand, Clermont Ferrand.
  • Chantepie S; Department of Hematology, CHU de Caen, Caen.
  • Deconinck E; Department of Hematology, CHU de Besançon, Besançon.
  • Daguindau E; Department of Hematology, CHU de Besançon, Besançon.
  • Contentin N; Department of Hematology, Centre Henri Becquerel, Rouen.
  • Yakoub-Agha I; LIRIC INSERM U995, Université Lille 2, CHU Lille, Lille.
  • Cornillon J; Department of Hematology, Institut de Cancérologie Lucien Neuwirth, Saint Etienne.
  • Mercier M; Department of Hematology, CHU d'Angers, Angers.
  • Turlure P; Department of Hematology, CHU de Limoges, Limoges.
  • Charbonnier A; Department of Hematology, CHU d'Amiens Sud, Amiens.
  • Rorhlich PS; Department of Hematology, CHU de Nice, Nice.
  • N'Guyen S; Department of Hematology, Hôpital Salpétrière, Paris.
  • Maillard N; Department of Hematology, Hôpital La Miletrie, Poitiers.
  • Marchand T; Department of Hematology, CHU de Rennes, Rennes, France.
  • Mohty M; Department of Hematology, Hôpital Saint Antoine, Paris.
  • Chevallier P; Department of Hematology, CHU Hôtel Dieu, Nantes.
Ann Oncol ; 28(9): 2191-2198, 2017 Sep 01.
Article em En | MEDLINE | ID: mdl-28911060
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vidarabina / Linfoma não Hodgkin / Bussulfano / Protocolos de Quimioterapia Combinada Antineoplásica / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vidarabina / Linfoma não Hodgkin / Bussulfano / Protocolos de Quimioterapia Combinada Antineoplásica / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article